The efficacy of progestin primed ovarian stimulation (PPOS) using Dienogest v.s. antagonist method during controlled ovarian stimulation(COS) for patients with endometriosis
Phase 4
Recruiting
- Conditions
- infertility
- Registration Number
- JPRN-UMIN000044076
- Lead Sponsor
- Kamiya Ladies Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who documented cycles with no oocyte retrieved, an y contraindications to ovarian stimulation treatment and 2) patients who has contraindication to DNG, GnRHa, EP, FSH, HMG, HCG 3) Using other hormonal therapy except Dienogest over 2 months before COS 4) Patients who is judged to be inappropriate for this study by th e doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The clinical pregnancy rate
- Secondary Outcome Measures
Name Time Method 1) total amount of FSH/HMG 2) number of growing follicle (<15mm) and mature follicle (<18m m), number of oocyte retrieved 3)the incidence of premature LH surge 4) fertilization rate, implantation rate 5) serum concentration of estradiol and progesterone (on the tri gger day) 6) the incidence of OHSS 7) the viable embryo rate 8) ongoing pregnancy rate, early miscarriage rate, multiple preg nancy rate